CD44 and colonic neoplasm: Compared with RNA-loaded DCs, DCs pulsed with lysates of colon cancer stem cells (CCSCs) isolated from CD44+ CT-26 colon cancer cells can evoke stronger anti-tumor immune responses against CCSCs (156).